Global Orphan Drugs Market Professional Survey Report 2016

November 2016 | 113 pages | ID: GDCBD2E2C93EN
QYResearch

Abstracts

Notes:

Production, means the output of Orphan Drugs

Revenue, means the sales value of Orphan Drugs

This report studies Orphan Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Bristol-Mayers Squibb
• Norartis
• Celgene
• Roche
• Pfizer
• Alexion
• Sanofi
• Vertes
• GSK
• Merck
• Johnson& Johnson

By types, the market can be split into

• New molecular entities drugs
• Biologics drugs
• Other

By Application, the market can be split into

• Oncologic
• Metabolic
• Hematologic-immunologic
• Infections/ parasitic
• Other

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

Contents

Global Orphan Drugs Market Professional Survey Report 2016

1 INDUSTRY OVERVIEW OF ORPHAN DRUGS

1.1 Definition and Specifications of Orphan Drugs
  1.1.1 Definition of Orphan Drugs
  1.1.2 Specifications of Orphan Drugs
1.2 Classification of Orphan Drugs
  1.2.1 New molecular entities drugs
  1.2.2 Biologics drugs
  1.2.3 Other
1.3 Applications of Orphan Drugs
  1.3.1 Oncologic
  1.3.2 Metabolic
  1.3.3 Hematologic-immunologic
  1.3.4 Infections/ parasitic
  1.3.5 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ORPHAN DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Orphan Drugs
2.3 Manufacturing Process Analysis of Orphan Drugs
2.4 Industry Chain Structure of Orphan Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ORPHAN DRUGS

3.1 Capacity and Commercial Production Date of Global Orphan Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Orphan Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Orphan Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Orphan Drugs Major Manufacturers in 2015

4 GLOBAL ORPHAN DRUGS OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2011-2016E Global Orphan Drugs Capacity and Growth Rate Analysis
  4.2.2 2015 Orphan Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2016E Global Orphan Drugs Sales and Growth Rate Analysis
  4.3.2 2015 Orphan Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2016E Global Orphan Drugs Sales Price
  4.4.2 2015 Orphan Drugs Sales Price Analysis (Company Segment)

5 ORPHAN DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Orphan Drugs Market Analysis
  5.1.1 North America Orphan Drugs Market Overview
  5.1.2 North America 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Orphan Drugs Sales Price Analysis
  5.1.4 North America 2015 Orphan Drugs Market Share Analysis
5.2 China Orphan Drugs Market Analysis
  5.2.1 China Orphan Drugs Market Overview
  5.2.2 China 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2011-2016E Orphan Drugs Sales Price Analysis
  5.2.4 China 2015 Orphan Drugs Market Share Analysis
5.3 Europe Orphan Drugs Market Analysis
  5.3.1 Europe Orphan Drugs Market Overview
  5.3.2 Europe 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2011-2016E Orphan Drugs Sales Price Analysis
  5.3.4 Europe 2015 Orphan Drugs Market Share Analysis
5.4 Southeast Asia Orphan Drugs Market Analysis
  5.4.1 Southeast Asia Orphan Drugs Market Overview
  5.4.2 Southeast Asia 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2011-2016E Orphan Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2015 Orphan Drugs Market Share Analysis
5.5 Japan Orphan Drugs Market Analysis
  5.5.1 Japan Orphan Drugs Market Overview
  5.5.2 Japan 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2011-2016E Orphan Drugs Sales Price Analysis
  5.5.4 Japan 2015 Orphan Drugs Market Share Analysis
5.6 India Orphan Drugs Market Analysis
  5.6.1 India Orphan Drugs Market Overview
  5.6.2 India 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Orphan Drugs Sales Price Analysis
  5.6.4 India 2015 Orphan Drugs Market Share Analysis

6 GLOBAL 2011-2016E ORPHAN DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Orphan Drugs Sales by Type
6.2 Different Types of Orphan Drugs Product Interview Price Analysis
6.3 Different Types of Orphan Drugs Product Driving Factors Analysis
  6.3.1 New molecular entities drugs of Orphan Drugs Growth Driving Factor Analysis
  6.3.2 Biologics drugs of Orphan Drugs Growth Driving Factor Analysis
  6.3.3 Other of Orphan Drugs Growth Driving Factor Analysis

7 GLOBAL 2011-2016E ORPHAN DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Orphan Drugs Consumption by Application
7.2 Different Application of Orphan Drugs Product Interview Price Analysis
7.3 Different Application of Orphan Drugs Product Driving Factors Analysis
  7.3.1 Oncologic of Orphan Drugs Growth Driving Factor Analysis
  7.3.2 Metabolic of Orphan Drugs Growth Driving Factor Analysis
  7.3.3 Hematologic-immunologic of Orphan Drugs Growth Driving Factor Analysis
  7.3.4 Infections/ parasitic of Orphan Drugs Growth Driving Factor Analysis
  7.3.5 Other of Orphan Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ORPHAN DRUGS

8.1 Bristol-Mayers Squibb
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Type I
    8.1.2.2 Type II
    8.1.2.3 Type III
  8.1.3 Bristol-Mayers Squibb 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Bristol-Mayers Squibb 2015 Orphan Drugs Business Region Distribution Analysis
8.2 Norartis
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Type I
    8.2.2.2 Type II
    8.2.2.3 Type III
  8.2.3 Norartis 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Norartis 2015 Orphan Drugs Business Region Distribution Analysis
8.3 Celgene
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Type I
    8.3.2.2 Type II
    8.3.2.3 Type III
  8.3.3 Celgene 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Celgene 2015 Orphan Drugs Business Region Distribution Analysis
8.4 Roche
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Type I
    8.4.2.2 Type II
    8.4.2.3 Type III
  8.4.3 Roche 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Roche 2015 Orphan Drugs Business Region Distribution Analysis
8.5 Pfizer
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Type I
    8.5.2.2 Type II
    8.5.2.3 Type III
  8.5.3 Pfizer 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Pfizer 2015 Orphan Drugs Business Region Distribution Analysis
8.6 Alexion
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Type I
    8.6.2.2 Type II
    8.6.2.3 Type III
  8.6.3 Alexion 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Alexion 2015 Orphan Drugs Business Region Distribution Analysis
8.7 Sanofi
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Type I
    8.7.2.2 Type II
    8.7.2.3 Type III
  8.7.3 Sanofi 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Sanofi 2015 Orphan Drugs Business Region Distribution Analysis
8.8 Vertes
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Type I
    8.8.2.2 Type II
    8.8.2.3 Type III
  8.8.3 Vertes 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Vertes 2015 Orphan Drugs Business Region Distribution Analysis
8.9 GSK
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Type I
    8.9.2.2 Type II
    8.9.2.3 Type III
  8.9.3 GSK 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 GSK 2015 Orphan Drugs Business Region Distribution Analysis
8.10 Merck
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Type I
    8.10.2.2 Type II
    8.10.2.3 Type III
  8.10.3 Merck 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Merck 2015 Orphan Drugs Business Region Distribution Analysis
8.11 Johnson& Johnson
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
    8.11.2.1 Type I
    8.11.2.2 Type II
    8.11.2.3 Type III
  8.11.3 Johnson& Johnson 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 Johnson& Johnson 2015 Orphan Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF ORPHAN DRUGS MARKET

9.1 Global Orphan Drugs Market Trend Analysis
  9.1.1 Global 2016-2021 Orphan Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Orphan Drugs Sales Price Forecast
9.2 Orphan Drugs Regional Market Trend
  9.2.1 North America 2016-2021 Orphan Drugs Consumption Forecast
  9.2.2 China 2016-2021 Orphan Drugs Consumption Forecast
  9.2.3 Europe 2016-2021 Orphan Drugs Consumption Forecast
  9.2.4 Southeast Asia 2016-2021 Orphan Drugs Consumption Forecast
  9.2.5 Japan 2016-2021 Orphan Drugs Consumption Forecast
  9.2.6 India 2016-2021 Orphan Drugs Consumption Forecast
9.3 Orphan Drugs Market Trend (Product Type)
9.4 Orphan Drugs Market Trend (Application)

10 ORPHAN DRUGS MARKETING TYPE ANALYSIS

10.1 Orphan Drugs Regional Marketing Type Analysis
10.2 Orphan Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Orphan Drugs by Regions
10.4 Orphan Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ORPHAN DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ORPHAN DRUGS MARKET PROFESSIONAL SURVEY REPORT 2016

Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Orphan Drugs
Table Product Specifications of Orphan Drugs
Table Classification of Orphan Drugs
Figure Global Production Market Share of Orphan Drugs by Type in 2015
Figure New molecular entities drugs Picture
Table Major Manufacturers of New molecular entities drugs
Figure Biologics drugs Picture
Table Major Manufacturers of Biologics drugs
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Orphan Drugs
Figure Global Consumption Volume Market Share of Orphan Drugs by Application in 2015
Figure Oncologic Examples
Table Major Consumers of Oncologic
Figure Metabolic Examples
Table Major Consumers of Metabolic
Figure Hematologic-immunologic Examples
Table Major Consumers of Hematologic-immunologic
Figure Infections/ parasitic Examples
Table Major Consumers of Infections/ parasitic
Figure Other Examples
Table Major Consumers of Other
Figure Market Share of Orphan Drugs by Regions
Figure North America Orphan Drugs Market Size (2011-2021)
Figure China Orphan Drugs Market Size (2011-2021)
Figure Europe Orphan Drugs Market Size (2011-2021)
Figure Southeast Asia Orphan Drugs Market Size (2011-2021)
Figure Japan Orphan Drugs Market Size (2011-2021)
Figure India Orphan Drugs Market Size (2011-2021)
Table Orphan Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Orphan Drugs in 2015
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Industry Chain Structure of Orphan Drugs
Table Capacity (K Units) and Commercial Production Date of Global Orphan Drugs Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Orphan Drugs Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Orphan Drugs Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Orphan Drugs Major Manufacturers in 2015
Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Orphan Drugs 2011-2016
Figure Global 2011-2016E Orphan Drugs Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Orphan Drugs Market Size (Value) and Growth Rate
Table 2011-2016E Global Orphan Drugs Capacity and Growth Rate
Table 2015 Global Orphan Drugs Capacity List (Company Segment)
Table 2011-2016E Global Orphan Drugs Sales and Growth Rate
Table 2015 Global Orphan Drugs Sales List (Company Segment)
Table 2011-2016E Global Orphan Drugs Sales Price
Table 2015 Global Orphan Drugs Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Orphan Drugs 2011-2016 (K Units)
Figure North America 2011-2016E Orphan Drugs Sales Price (USD/Unit)
Figure North America 2015 Orphan Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Orphan Drugs 2011-2016 (K Units)
Figure China 2011-2016E Orphan Drugs Sales Price (USD/Unit)
Figure China 2015 Orphan Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Orphan Drugs 2011-2016 (K Units)
Figure Europe 2011-2016E Orphan Drugs Sales Price (USD/Unit)
Figure Europe 2015 Orphan Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Orphan Drugs 2011-2016 (K Units)
Figure Southeast Asia 2011-2016E Orphan Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2015 Orphan Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Orphan Drugs 2011-2016 (K Units)
Figure Japan 2011-2016E Orphan Drugs Sales Price (USD/Unit)
Figure Japan 2015 Orphan Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Orphan Drugs 2011-2016 (K Units)
Figure India 2011-2016E Orphan Drugs Sales Price (USD/Unit)
Figure India 2015 Orphan Drugs Sales Market Share
Table Global 2011-2016E Orphan Drugs Sales by Type
Table Different Types Orphan Drugs Product Interview Price
Table Global 2011-2016E Orphan Drugs Sales by Application
Table Different Application Orphan Drugs Product Interview Price
Table Bristol-Mayers Squibb Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Bristol-Mayers Squibb Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Bristol-Mayers Squibb 2015 Orphan Drugs Business Region Distribution
Table Norartis Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Norartis Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Norartis 2015 Orphan Drugs Business Region Distribution
Table Celgene Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Celgene Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Celgene 2015 Orphan Drugs Business Region Distribution
Table Roche Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Roche Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Roche 2015 Orphan Drugs Business Region Distribution
Table Pfizer Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Pfizer Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Pfizer 2015 Orphan Drugs Business Region Distribution
Table Alexion Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Alexion Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Alexion 2015 Orphan Drugs Business Region Distribution
Table Sanofi Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Sanofi Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Sanofi 2015 Orphan Drugs Business Region Distribution
Table Vertes Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Vertes Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Vertes 2015 Orphan Drugs Business Region Distribution
Table GSK Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 GSK Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 GSK 2015 Orphan Drugs Business Region Distribution
Table Merck Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Merck Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Merck 2015 Orphan Drugs Business Region Distribution
Table Johnson& Johnson Information List
Table Type I Orphan Drugs Overview
Table Type II Orphan Drugs Overview
Table Type III Orphan Drugs Overview
Table 2015 Johnson& Johnson Orphan Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Johnson& Johnson 2015 Orphan Drugs Business Region Distribution
Figure Global 2016-2021 Orphan Drugs Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Orphan Drugs Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Orphan Drugs Sales Price (USD/Unit) Forecast
Figure North America 2016-2021 Orphan Drugs Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Orphan Drugs Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Orphan Drugs Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Orphan Drugs Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Orphan Drugs Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Orphan Drugs Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K Units) of Orphan Drugs by Types 2016-2021
Table Global Consumption Volume (K Units) of Orphan Drugs by Applications 2016-2021
Table Traders or Distributors with Contact Information of Orphan Drugs by Regions
Table Part of Interviewees Record List